Plexus Announces Fiscal Second Quarter Financial Results

Plexus delivered strong results, but future growth claims still need to be proven.

What the company is saying

Plexus Corp. is positioning itself as a growth-focused, operationally disciplined technology manufacturer, highlighting record financial performance in its fiscal second quarter 2026. The company wants investors to believe that its business is not only expanding rapidly—evidenced by a 19% year-over-year revenue increase to $1.164 billion—but also that this growth is sustainable and underpinned by operational excellence. Management emphasizes the achievement of record revenue, a solid GAAP operating margin of 5.3%, and a GAAP diluted EPS of $1.82, framing these as validation of their strategy. The announcement spotlights the win of 30 new manufacturing programs, which are projected to add $355 million in annualized revenue once fully ramped, and the company’s ability to generate $16.0 million in free cash flow. Shareholder returns are also highlighted through the repurchase of $20.6 million in shares at an average price of $189.22, with $42.0 million remaining under the current authorization. The company’s forward-looking guidance for Q3F26 is presented confidently, projecting revenue of $1.200–$1.250 billion and non-GAAP EPS of $2.02–$2.18, while clearly distinguishing between GAAP and non-GAAP metrics. Notably, the announcement is silent on dividends and debt levels, and there is no mention of new products, M&A, or major strategic pivots. The tone is upbeat but measured, with President and CEO Todd Kelsey and CFO Patrick Jermain named as key spokespeople, lending institutional credibility but not introducing any outside high-profile investors. This narrative fits a classic investor relations playbook: focus on operational wins, provide clear near-term guidance, and avoid overpromising on long-term, unproven initiatives. There is no evidence of a major shift in messaging compared to prior communications, as the company sticks to reporting realised results and standard forward-looking guidance.

What the data suggests

The disclosed numbers show that Plexus is currently on a strong financial trajectory. Fiscal second quarter 2026 revenue reached a record $1.164 billion, up 19% year-over-year, which is a clear sign of accelerating top-line growth. The GAAP operating margin of 5.3% and non-GAAP operating margin of 6.0% indicate solid profitability, while the GAAP diluted EPS of $1.82 and non-GAAP EPS of $2.05 (excluding $0.23 of stock-based compensation) demonstrate strong earnings power. Free cash flow for the quarter was $16.0 million, derived from $28.5 million in cash flows from operations minus $12.5 million in capital expenditures, confirming the company’s stated definition. The cash cycle improved by 5 days sequentially to 64 days, suggesting better working capital management. Return on invested capital (ROIC) was 13.8%, and economic return was 4.8%, both healthy figures for the sector. The company’s top 10 customers accounted for 54% of revenue, indicating some customer concentration risk but also strong relationships with key accounts. Segment and geographic breakdowns are provided, with the Americas, Asia-Pacific, and EMEA contributing $397 million, $652 million, and $116 million respectively, and Healthcare/Life Sciences and Industrial each making up 41% of revenue. All realised claims are supported by the data, and the guidance for Q3F26 (revenue of $1.200–$1.250 billion, GAAP EPS of $1.25–$1.41, non-GAAP EPS of $2.02–$2.18) is clearly identified as forward-looking. There are no missing key metrics for the reported period, but the absence of direct period-over-period margin and EPS comparisons limits full trend analysis. An independent analyst would conclude that the company is executing well, with realised growth and profitability, but would note that future guidance remains to be proven.

Analysis

The announcement is primarily focused on realised, measurable financial results for the fiscal second quarter 2026, including record revenue, margins, EPS, and free cash flow, all of which are supported by disclosed numerical data. Forward-looking statements are limited to standard quarterly guidance for the next quarter, which is a routine and expected disclosure in earnings releases. There is no evidence of exaggerated or aspirational language; the tone is positive but proportionate to the results. Capital expenditures and share repurchases are disclosed, but these are not unusually large relative to the company's scale, and there is no indication of a major capital outlay with uncertain long-term returns. The gap between narrative and evidence is minimal, with all key claims either realised or clearly identified as guidance.

Risk flags

• ●Customer concentration risk is significant, with the top 10 customers accounting for 54% of revenue in Q2F26. This means that the loss or reduction of business from any major customer could materially impact results, and investors should monitor for any signs of customer churn or renegotiation.
• ●Forward-looking guidance for Q3F26 and the ramp-up of $355 million in annualized revenue from new programs are not yet realised. While the company has a track record of execution, these projections are inherently uncertain and subject to operational and market risks.
• ●The announcement omits any discussion of debt levels or dividend payments. This lack of disclosure leaves investors without a full picture of the company’s capital structure and shareholder return policy, which could mask potential financial risks.
• ●Capital expenditures were $12.5 million in Q2F26, and the company is 'strategically increasing working capital investments.' While not excessive, this signals ongoing capital intensity, which could pressure free cash flow if growth slows or margins compress.
• ●The company’s share repurchase activity—$20.6 million in Q2F26—returns capital to shareholders, but also reduces cash reserves. If future cash generation falters, this could limit financial flexibility.
• ●Geographic revenue exposure includes the United States, China, Taiwan, and other regions. Any geopolitical or supply chain disruptions in these areas could impact operations and financial results, especially given current global tensions.
• ●The majority of the company’s claims about future growth are forward-looking, including revenue and EPS guidance for Q3F26 and the full ramp of new manufacturing programs. Investors should be cautious about treating these as certain until realised results are reported.
• ●There is no evidence of notable outside institutional investors or strategic partners participating in this quarter, which means the results rest solely on management’s execution and do not benefit from external validation or support.

Bottom line

For investors, this announcement means Plexus is currently delivering on its operational and financial promises, with record revenue, solid margins, and positive free cash flow in Q2F26. The company’s narrative is credible for the realised period, as all key claims are supported by disclosed numbers and there is no evidence of hype or overstatement. However, the forward-looking guidance for Q3F26 and the ramp-up of new manufacturing programs remain unproven and should be treated as targets rather than guarantees. The absence of any discussion of debt or dividends is a notable gap, and investors should seek more information on the company’s capital structure and long-term shareholder return policy. Key metrics to watch in the next reporting period include actual Q3F26 revenue, margins, EPS, free cash flow, and progress on the $355 million in new program revenue. This information is worth monitoring closely, but not acting on until further results confirm the company’s ability to sustain growth and profitability. The most important takeaway is that Plexus is executing well today, but future growth still needs to be demonstrated in realised results before investors should materially increase their exposure.

Announcement summary

Plexus Corp. (NASDAQ: PLXS) announced record fiscal second quarter 2026 revenue of $1.164 billion, a 19% year-over-year increase, with a GAAP operating margin of 5.3% and GAAP diluted EPS of $1.82. The company reported non-GAAP operating margin of 6.0% and non-GAAP diluted EPS of $2.05, excluding $0.23 of stock-based compensation expense. Plexus won 30 manufacturing programs during the quarter, representing a record $355 million in annualized revenue when fully ramped into production. The company generated $16.0 million in free cash flow and repurchased $20.6 million of its shares. Guidance for the fiscal third quarter 2026 includes revenue of $1.200 billion to $1.250 billion and GAAP diluted EPS of $1.25 to $1.41.

Disagree with this article?